
|Articles|June 13, 2014
Positive CHMP opinion for glaucoma drops
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for brinzolamide 10 mg/mL and brimonidine tartrate 2 mg/mL eye drops suspension (Simbrinza, Alcon) to decrease elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension, for whom monotherapy provides insufficient IOP reduction.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Beyond anti-VEGF: The next wave in retinal therapy
2
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
3
Trehalose-hyaluronate combination aids tear film after eyelid surgery
4
ZEISS reports early implantations of AT LUCIA Toric 721P IOL in Europe
5




















